Fennec Pharma-Adherex Technologies Inc. (FENC) Reports Q4 Loss, Misses Revenue Estimates

Adherex Technologies Inc. (FENC) came out with a quarterly loss of $0.06 per share versus the Zacks Consensus Estimate of$ 0.56. This compares to loss of $0.10 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of -110.71%. A quarter ago, it was expected that this company would post a loss of$ 0.13 per share when it actually produced a loss of $0.21, delivering a surprise of -61.54%.Over the last four quarters, the company has not b ...